StockWatch
·

BAL PHARMA LTD. Q3 FY26 Results

BALPHARMAQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue87.6918.5%19.9%
Total Income88.0217.1%19.5%
Expenditure86.2315.9%18.0%
PBT1.79149.6%216.4%
Net Profit1.79149.6%245.7%
OPM10.89%3.15pp21.33pp
NPM2.03%1.08pp1.33pp
EPS1.12148.9%239.4%
View full financials

Informational and educational content only. Not investment advice.